Mathieu Lane

Mathieu Lane has over 25 years of work experience in the finance and healthcare sector. Mathieu began their career at Genzyme as a Senior Research Associate in Gene Therapy R&D. Mathieu then moved on to work at Bear Stearns & Co. as a Vice President. Following that, they joined SR One Capital Management as a Partner and Finance Director. Mathieu later transitioned to Guggenheim Securities Investment Banking, where they worked as a Managing Director for over a decade. Mathieu then joined eTheRNA immunotherapies as the Chief Financial Officer before ultimately becoming the Head of Healthcare Investment Banking at Berenberg Capital Markets in 2023.

From 1999 to 2001, Mathieu Lane attended NYU Stern School of Business, where they pursued a Master of Business Administration (MBA) degree with a specialization in Finance and Accounting.